Table 1.

Baseline Characteristics of Study Participants (by Outcome)

	KS regressors or stable disease	KS progressors
Age in years [IQR]	33 [30–39]	33 [31–43]
Males	9 (64%)	6 (43%)
Smoking	8 (57%)	4 (29%)
Alcohol	10 (71%)	12 (86%)
Months since first lesion [IQR]	3 [3–9]	3 [2–6]
Days since HIV diagnosis [IQR]	14 [2–30]	7 [3–30]
Days on ART [IQR]	2 [0–14]	6 [2–14]
Lesions in mucous membranes	6 (43%)	5 (38%)
More than 5 KS lesions present	9 (69%)	10 (71%)
CD4 count as cells/μL [IQR]	88 [53–234]	128 [109–223]
HIV viral load as copies/mL [IQR]	30,539 [1,125–489,428]	20,033 [1,693–180,726]

ART, antiretroviral therapy; IQR, interquartile range; KS, Kaposi's sarcoma.